These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept. Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573 [TBL] [Abstract][Full Text] [Related]
4. Development of novel radionuclides for medical applications. Qaim SM; Spahn I J Labelled Comp Radiopharm; 2018 Mar; 61(3):126-140. PubMed ID: 29110328 [TBL] [Abstract][Full Text] [Related]
5. Production of Sn-117m in the BR2 high-flux reactor. Ponsard B; Srivastava SC; Mausner LF; Russ Knapp FF; Garland MA; Mirzadeh S Appl Radiat Isot; 2009; 67(7-8):1158-61. PubMed ID: 19303313 [TBL] [Abstract][Full Text] [Related]
7. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain. Liepe K; Runge R; Kotzerke J J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184 [TBL] [Abstract][Full Text] [Related]
8. Nuclear data for production and medical application of radionuclides: Present status and future needs. Qaim SM Nucl Med Biol; 2017 Jan; 44():31-49. PubMed ID: 27821344 [TBL] [Abstract][Full Text] [Related]
9. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres. Bardiès M; Chatal JF Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573 [TBL] [Abstract][Full Text] [Related]
11. Radionuclide production for therapeutic radiopharmaceuticals. Neves M; Kling A; Lambrecht RM Appl Radiat Isot; 2002 Nov; 57(5):657-64. PubMed ID: 12433039 [TBL] [Abstract][Full Text] [Related]
12. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions. Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569 [TBL] [Abstract][Full Text] [Related]
14. Cancer therapy using bone-seeking isotopes. Lewington VJ Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic radionuclides in nuclear medicine: current and future prospects. Yeong CH; Cheng MH; Ng KH J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374 [TBL] [Abstract][Full Text] [Related]
16. Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer. Bishayee A; Rao DV; Srivastava SC; Bouchet LG; Bolch WE; Howell RW J Nucl Med; 2000 Dec; 41(12):2043-50. PubMed ID: 11138691 [TBL] [Abstract][Full Text] [Related]
17. [Use of radionuclides in therapy]. Vucina J; Han R Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220 [TBL] [Abstract][Full Text] [Related]
18. [Application of radiometallic compounds for medical diagnosis and therapy]. Saji H Yakugaku Zasshi; 2008 Mar; 128(3):323-32. PubMed ID: 18311050 [TBL] [Abstract][Full Text] [Related]
19. Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine. Pillai AM; Knapp FF Curr Radiopharm; 2015; 8(2):78-85. PubMed ID: 25771380 [TBL] [Abstract][Full Text] [Related]
20. Production logistics and radionuclidic purity aspects of 153Sm for radionuclide therapy. Ramamoorthy N; Saraswathy P; Das MK; Mehra KS; Ananthakrishnan M Nucl Med Commun; 2002 Jan; 23(1):83-9. PubMed ID: 11748442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]